Investors
Statement on Supreme Court ruling
We do not expect that this case triggers a major change in the relationship between providers and health insurers as the vast majority of those in the industry are interested in the well-being of patients. To limit coverage for certain conditions is in our view not an appropriate or ethical behavior and raises a significant health equity issue for patients living with kidney disease.
Report on 2nd quarter 2022: Earnings Release and Conference Call
Report on 3rd quarter 2022: Earnings Release and Conference Call
Order our news
Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.
You can cancel this free service at any time by sending an e-mail to
ir(at)fmc-ag.com, or by calling +49 (0) 6172 - 609 2525.
The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our
privacy policy.
Order form
Here you may order printed copies of our magazines, profiles and SEC filings.
In order to protect the environment and better meet the changing user behavior of our target groups, the annual report as well as our quarterly financial reports are published as digital publications only.